FI102679B1 - Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjohdannaisten valmistamiseksi

Info

Publication number
FI102679B1
FI102679B1 FI931472A FI931472A FI102679B1 FI 102679 B1 FI102679 B1 FI 102679B1 FI 931472 A FI931472 A FI 931472A FI 931472 A FI931472 A FI 931472A FI 102679 B1 FI102679 B1 FI 102679B1
Authority
FI
Finland
Prior art keywords
sertindole
group
preparation
therapeutically useful
prodrug derivatives
Prior art date
Application number
FI931472A
Other languages
English (en)
Swedish (sv)
Other versions
FI931472A (fi
FI102679B (fi
FI931472A0 (fi
Inventor
Jens Kristian Perregaard
Henrik Pedersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of FI931472A publication Critical patent/FI931472A/fi
Publication of FI931472A0 publication Critical patent/FI931472A0/fi
Application granted granted Critical
Publication of FI102679B1 publication Critical patent/FI102679B1/fi
Publication of FI102679B publication Critical patent/FI102679B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
FI931472A 1990-10-03 1993-04-01 Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjo hdannaisten valmistamiseksi FI102679B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK238190A DK238190D0 (da) 1990-10-03 1990-10-03 Depotderivater
DK238190 1990-10-03
PCT/DK1991/000291 WO1992006089A1 (en) 1990-10-03 1991-09-27 Sertindole prodrugs
DK9100291 1991-09-27

Publications (4)

Publication Number Publication Date
FI931472A FI931472A (fi) 1993-04-01
FI931472A0 FI931472A0 (fi) 1993-04-01
FI102679B1 true FI102679B1 (fi) 1999-01-29
FI102679B FI102679B (fi) 1999-01-29

Family

ID=8111993

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931472A FI102679B (fi) 1990-10-03 1993-04-01 Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjo hdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US5428036A (fi)
EP (1) EP0592433B1 (fi)
JP (1) JP3100980B2 (fi)
KR (1) KR100212430B1 (fi)
AT (1) ATE175964T1 (fi)
AU (1) AU652783B2 (fi)
CA (1) CA2093433C (fi)
DE (1) DE69130803T2 (fi)
DK (2) DK238190D0 (fi)
ES (1) ES2125870T3 (fi)
FI (1) FI102679B (fi)
GR (1) GR3029399T3 (fi)
HK (1) HK1009273A1 (fi)
IE (1) IE913384A1 (fi)
IL (1) IL99652A (fi)
NO (1) NO301475B1 (fi)
NZ (1) NZ240051A (fi)
PH (1) PH30129A (fi)
PT (1) PT99142B (fi)
WO (1) WO1992006089A1 (fi)
ZA (1) ZA917881B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
JPH0625964U (ja) * 1992-05-25 1994-04-08 ミクロン機器株式会社 通信機能付きコインカウンタ及び有料装置
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
JP4634694B2 (ja) 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
WO2002076402A2 (en) * 2001-03-23 2002-10-03 Protarga, Inc. Fatty amine drug conjugates
US20100168197A1 (en) * 2007-02-28 2010-07-01 Naresh Kumar Muscarinic receptor antagonists
LT2445502T (lt) * 2009-06-25 2017-09-25 Alkermes Pharma Ireland Limited Heterocikliniai junginiai, skirti neurologinių ir fiziologinių susirgimų gydymui
US8686009B2 (en) * 2009-06-25 2014-04-01 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds
AU2011270701B2 (en) * 2010-06-24 2015-05-14 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
US4038305A (en) * 1972-03-20 1977-07-26 Aktieselskabet Grindstedvaerket Cyclopentenone derivatives
GB1469108A (en) * 1973-06-25 1977-03-30 Kefalas As Thiaxanthene derivative
JPS568318A (en) * 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8621892D0 (en) * 1986-09-11 1986-10-15 Lundbeck & Co As H Organic compound
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DE3921886A1 (de) * 1989-07-04 1991-01-17 Wolfgang Mohr Vorrichtung zum schneiden von gestapeltem, blattfoermigen gut

Also Published As

Publication number Publication date
IL99652A (en) 1997-04-15
GR3029399T3 (en) 1999-05-28
IL99652A0 (en) 1992-08-18
KR930702335A (ko) 1993-09-08
ATE175964T1 (de) 1999-02-15
NO931219D0 (no) 1993-03-31
AU652783B2 (en) 1994-09-08
AU8710491A (en) 1992-04-28
NO931219L (no) 1993-04-01
US5428036A (en) 1995-06-27
CA2093433A1 (en) 1992-04-04
EP0592433B1 (en) 1999-01-20
DK238190D0 (da) 1990-10-03
IE913384A1 (en) 1992-04-08
PT99142B (pt) 1999-04-30
DE69130803D1 (de) 1999-03-04
FI931472A (fi) 1993-04-01
FI102679B (fi) 1999-01-29
FI931472A0 (fi) 1993-04-01
KR100212430B1 (ko) 1999-08-02
CA2093433C (en) 2000-11-21
NO301475B1 (no) 1997-11-03
NZ240051A (en) 1993-05-26
ES2125870T3 (es) 1999-03-16
HK1009273A1 (en) 1999-05-28
EP0592433A1 (en) 1994-04-20
PH30129A (en) 1997-01-21
DK0592433T3 (da) 1999-09-13
WO1992006089A1 (en) 1992-04-16
DE69130803T2 (de) 1999-08-19
JPH06501939A (ja) 1994-03-03
JP3100980B2 (ja) 2000-10-23
ZA917881B (en) 1992-07-29
PT99142A (pt) 1994-02-28

Similar Documents

Publication Publication Date Title
FI102679B1 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sertindoli-prodrugjohdannaisten valmistamiseksi
ATE25251T1 (de) Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
ATE1899T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
PT76316A (en) Process for the preparation of esters of substituted pyridino- 3,5-dicarboxylic and/or of pyrano-3,5-dicarboxylic acids having an hypotensive effect and application thereof for the preparation of pharmaceutical compositions having an hypotensive effect
IL104305A0 (en) Piperazine derivatives,their preparation and pharmaceutical compositions containing them
ATE14579T1 (de) Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
AT397654B (de) Neue pleuromutilinderivate, ihre verwendung und verfahren zu ihrer herstellung
KR930021642A (ko) 9-플루오로-7-옥소-7h-피리도[1,2,3-데][1,4]벤족사진-6-카르복실산 및 에스테르
MY103502A (en) Novel compounds
KR880006239A (ko) 기라제 억제제, 그의 제조방법 및 용도
ES8200323A1 (es) Procedimiento de preparacion de esteres de derivados de la aletrolona y de acidos ciclopropeno-carboxilicos
ATE113958T1 (de) Organische ester der alkoholischen derivate der 19-nor-steroide und die salze davon, verfahren zu deren herstellung und zwischenprodukte davon, ihre verwendung als arzneimittel und pharmazeutische präparate davon.
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
EG19557A (en) A process for the preparation of pharmaceutical preparation
ES8301479A1 (es) Un procedimiento para la preparacion de antibioticos de b-lactama.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR950017965A (ko) 3-(페닐알킬아미노알킬옥시)-5-페닐피라졸 화합물과 그 제조공정 그리고 제조중의 중간산물 및 이 화합물을 함유하는 의약품
ES8305304A1 (es) "procedimiento de preparacion de derivados de etanolamina".
MA18964A1 (fr) 2-aminoalkyl-5-pyridinols,procede pour leur preparation,compositions pharmaceutiques contenant ces composes et leurs utilisations therapeutiques
GB969790A (en) New aminoalkyl aryloxyalkanoic esters of use as local anaesthetics and a process for their preparation
ES8200112A1 (es) Un procedimiento para la preparacion de un derivado del aci do clavulanico.
ES8404989A1 (es) Un procedimiento para preparar 4-(2-hidroxietil)-2-azetidinona opticamente activa.

Legal Events

Date Code Title Description
MA Patent expired